Prediabetes in a French overseas territory: Clinical Characteristics, Risk Factors, and Implications for type 2 diabetes prevention.

Finnish Diabetes Risk Score (FINDRISC) Prediabetes Primary Care Reunion Island Risk Factors

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Nov 2024
Historique:
received: 30 05 2024
revised: 20 09 2024
accepted: 21 09 2024
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 11 10 2024
Statut: epublish

Résumé

People with prediabetes are at high risk of developing type 2 diabetes (T2D). This study evaluates clinical, sociodemographic characteristics, and Finnish Diabetes Risk Score (FINDRISC) of individuals with prediabetes recruited in primary care by their general practitioner (GP) for PREDIABRUN study. PREDIABRUN, a prospective cohort study in primary care on Reunion Island, aimed to identify risk factors for developing T2D in 500 adults with prediabetes (18-70 years) between July 2019 and December 2022. Sociodemographic, anthropometric, health, and lifestyle data were collected. Participants were categorized as having known prediabetes if their GP was aware of glucose abnormalities before the study, otherwise as newly diagnosed. A total of 469 subjects were included, with a median age of 55 years; 58.4 % were women. Employment was more common among men (53.3 %) than women (36.1 %). Precariousness affected 35.4 % overall, with higher rates in women (41.6 %) than men (26.7 %, p < 0.001). The major associated health issues were obesity (40.1 %), musculoskeletal disorders (50.5 %), hypertension (46.3 %) and cardiovascular diseases (11.5 %). The median FINDRISC score was 16 [IQR: 12-19], higher in women (17 [14-20]) than men (15 [11-17], p < 0.001). For more than half the population (55.0 %), prediabetes status was already known. However, lifestyle habits were similar for those with newly diagnosed prediabetes and those with prediabetes already known. Screened population in primary care on Reunion Island is relatively young, with a high FINDRISC score and numerous medical conditions. Tailored intervention to improve dietary habits and increase physical activity could help prevent diabetes in this high-risk group.

Sections du résumé

Background UNASSIGNED
People with prediabetes are at high risk of developing type 2 diabetes (T2D). This study evaluates clinical, sociodemographic characteristics, and Finnish Diabetes Risk Score (FINDRISC) of individuals with prediabetes recruited in primary care by their general practitioner (GP) for PREDIABRUN study.
Methods UNASSIGNED
PREDIABRUN, a prospective cohort study in primary care on Reunion Island, aimed to identify risk factors for developing T2D in 500 adults with prediabetes (18-70 years) between July 2019 and December 2022. Sociodemographic, anthropometric, health, and lifestyle data were collected. Participants were categorized as having known prediabetes if their GP was aware of glucose abnormalities before the study, otherwise as newly diagnosed.
Results UNASSIGNED
A total of 469 subjects were included, with a median age of 55 years; 58.4 % were women. Employment was more common among men (53.3 %) than women (36.1 %). Precariousness affected 35.4 % overall, with higher rates in women (41.6 %) than men (26.7 %, p < 0.001). The major associated health issues were obesity (40.1 %), musculoskeletal disorders (50.5 %), hypertension (46.3 %) and cardiovascular diseases (11.5 %). The median FINDRISC score was 16 [IQR: 12-19], higher in women (17 [14-20]) than men (15 [11-17], p < 0.001). For more than half the population (55.0 %), prediabetes status was already known. However, lifestyle habits were similar for those with newly diagnosed prediabetes and those with prediabetes already known.
Conclusion UNASSIGNED
Screened population in primary care on Reunion Island is relatively young, with a high FINDRISC score and numerous medical conditions. Tailored intervention to improve dietary habits and increase physical activity could help prevent diabetes in this high-risk group.

Identifiants

pubmed: 39391285
doi: 10.1016/j.pmedr.2024.102893
pii: S2211-3355(24)00308-5
pmc: PMC11464243
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102893

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

René Bun (R)

INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) 1410, CHU de La Réunion, Saint-Pierre, La Réunion, France.

Babacar Tounkara (B)

INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) 1410, CHU de La Réunion, Saint-Pierre, La Réunion, France.

Sébastien Leruste (S)

INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) 1410, CHU de La Réunion, Saint-Pierre, La Réunion, France.
Département universitaire de médecine générale (DUMG), Université de La Réunion, France.

Laurie Kichenapanaidou (L)

INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) 1410, CHU de La Réunion, Saint-Pierre, La Réunion, France.

Mathilde Simonson (M)

Service d'Endocrinologie, Diabète et Nutrition, CHU de La Réunion, Saint-Pierre, La Réunion, France.
Université de La Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), Plateforme CYROI, Saint-Denis, La Réunion, France.

Christine Kowalczyk (C)

Union régionale des médecins libéraux Océan Indien (URML), La Réunion, France.

Jean-Marc Franco (JM)

INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) 1410, CHU de La Réunion, Saint-Pierre, La Réunion, France.
Département universitaire de médecine générale (DUMG), Université de La Réunion, France.

Catherine Marimoutou (C)

INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) 1410, CHU de La Réunion, Saint-Pierre, La Réunion, France.

Estelle Nobécourt (E)

INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) 1410, CHU de La Réunion, Saint-Pierre, La Réunion, France.
Service d'Endocrinologie, Diabète et Nutrition, CHU de La Réunion, Saint-Pierre, La Réunion, France.
Université de La Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), Plateforme CYROI, Saint-Denis, La Réunion, France.

Classifications MeSH